Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA proposed timeframe for supplement health claims decisions "excessive," NHA charges.

This article was originally published in The Tan Sheet

Executive Summary

FDA TIMEFRAME FOR SUPPLEMENT HEALTH CLAIM DECISIONS "EXCESSIVE," NHA asserts in April 15 comments on the agency's proposed rule that sets a time limit for when it will issue final rules on health claims for dietary supplements and conventional foods. Under the March 17 proposed rule, FDA has up to 270 days after the publication date of a proposed health claim to authorize or reject use of the claim ("The Tan Sheet" March 17, p. 13).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS086927

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel